title: An fMRI-Based Neural Signature of Decisions to Smoke Cannabis.
abstract: Drug dependence may be at its core a pathology of choice, defined by continued decisions to use drugs irrespective of negative consequences. Despite evidence of dysregulated decision making in addiction, little is known about the neural processes underlying the most clinically relevant decisions drug users make: decisions to use drugs. Here, we combined functional magnetic resonance imaging (fMRI), machine learning, and human laboratory drug administration to investigate neural activation underlying decisions to smoke cannabis. Nontreatment-seeking daily cannabis smokers completed an fMRI choice task, making repeated decisions to purchase or decline 1-12 placebo or active cannabis 'puffs' ($0.25-$5/puff). One randomly selected decision was implemented. If the selected choice had been bought, the cost was deducted from study earnings and the purchased cannabis smoked in the laboratory; alternatively, the participant remained in the laboratory without cannabis. Machine learning with leave-one-subject-out cross-validation identified distributed neural activation patterns discriminating decisions to buy cannabis from declined offers. A total of 21 participants were included in behavioral analyses; 17 purchased cannabis and were thus included in fMRI analyses. Purchasing varied lawfully with dose and cost. The classifier discriminated with 100% accuracy between fMRI activation patterns for purchased vs declined cannabis at the level of the individual. Dorsal striatum, insula, posterior parietal regions, anterior and posterior cingulate, and dorsolateral prefrontal cortex all contributed reliably to this neural signature of decisions to smoke cannabis. These findings provide the basis for a brain-based characterization of drug-related decision making in drug abuse, including effects of psychological and pharmacological interventions on these processes.
authors.affiliation: Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA.|Division on Substance Abuse, New York State Psychiatric Institute, New York, NY, USA.
authors.forename: Gillinder
authors.initials: G
authors.lastname: Bedi
authors.affiliation: Department of Biostatistics, Johns Hopkins University, Baltimore, MD, USA.
authors.forename: Martin A
authors.initials: MA
authors.lastname: Lindquist
authors.affiliation: Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA.|Division on Substance Abuse, New York State Psychiatric Institute, New York, NY, USA.
authors.forename: Margaret
authors.initials: M
authors.lastname: Haney
mesh_terms: D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D001921:Brain / Q000098:blood supply*; D001931:Brain Mapping; D002188:Cannabis / Q000009:adverse effects; D002755:Choice Behavior / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D058999:Drug-Seeking Behavior / Q000502:physiology*; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008297:Male; D008385:Marijuana Smoking / Q000473:pathology / Q000503:physiopathology / Q000523:psychology; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D055815:Young Adult
chemical_list: D010100:Oxygen